RDIF announces Sputnik V efficacy data from San Marino
Kirill Dmitriev, CEO, RDIF; Alexander Gintsburg, Director and Denis Logunov, Deputy Director, Gamaleya Center participated in a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Russian Direct Investment Fund
AstraZeneca and Sputnik V combination show no adverse events: RFID
The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik…
Serum Institute to start manufacturing Sputnik vaccine in September
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
The first batch will be shipped to the Gamaleya Center for the quality control
Panacea Biotec gets license to manufacture Sputnik V vaccine at Baddi, Himachal Pradesh
Sputnik V was registered in India under the emergency use authorisation procedure on April 12, 2021, and vaccination against…
RDIF, UNICEF sign agreement for supply of 220 million doses of Sputnik V vaccine
Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered…
Dr Reddy’s, RDIF in discussions on production of Sputnik V for other countries
In addition, there are discussions with RDIF for Sputnik light, a single dose vaccine for COVID-19 being developed in Russia as…
Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for Sputnik V vaccine
The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group,…
Dr Reddy’s announces Sputnik V meets primary endpoint of safety in Phase 2 trial in India
Dr Reddy’s submitted the phase 2 safety data for DCGI’s approval to continue phase 3 clinical trials
Dr Reddy’s and RDIF begin clinical trials for Sputnik V vaccine in India
The clinical trials are being conducted by JSS Medical Research as the clinical research partner